Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.98%34.67B | -7.34%33.34B | -24.96%8.45B | -24.24%8.3B | 18.04%8.48B | 23.18%8.12B | 42.21%35.98B | 81.38%11.26B | 51.91%10.95B | 17.90%7.18B |
| Cost of revenue | 0.89%28.03B | -7.70%27.78B | -26.44%6.69B | -25.82%6.99B | 17.53%7.14B | 26.50%6.95B | 51.64%30.1B | 74.94%9.09B | 64.40%9.43B | 26.39%6.08B |
| Gross profit | 19.45%6.64B | -5.49%5.56B | -18.73%1.76B | -14.40%1.3B | 20.87%1.33B | 6.54%1.17B | 7.91%5.89B | 114.53%2.17B | 3.28%1.52B | -14.00%1.1B |
| Operating expense | 13.74%2.71B | 13.35%2.38B | 5.50%619.84M | 20.15%606.61M | 9.24%565.74M | 20.05%591.62M | 7.49%2.1B | 17.69%587.55M | 4.79%504.87M | 8.72%517.88M |
| Operating profit | 23.73%3.93B | -15.96%3.18B | -27.75%1.14B | -31.57%695.39M | 31.20%765.1M | -4.47%577.63M | 8.14%3.78B | 209.27%1.58B | 2.54%1.02B | -27.46%583.17M |
| Net non-operating interest income (expenses) | -115.69%-141.71M | -78.13%-65.7M | -329.35%-26.23M | -47.95%-14.71M | -18.50%-11.81M | -19.21%-12.95M | 0.88%-36.88M | 25.99%-6.11M | -31.62%-9.95M | 16.53%-9.96M |
| Non-operating interest income | 1,299.31%6.09M | -23.01%435K | -66.67%77K | 95.92%96K | -6.81%219K | -14.00%43K | -13.48%565K | -7.97%231K | -12.50%49K | -18.69%235K |
| Non-operating interest expense | 123.48%147.79M | 76.60%66.13M | 314.92%26.3M | 48.19%14.81M | 17.91%12.03M | 19.06%13M | -1.10%37.45M | -25.46%6.34M | 31.29%9.99M | -16.58%10.2M |
| Net investment income | 22.59%888.07M | 21.91%724.41M | 69.34%38.43M | 23.53%321.92M | 15.47%25.72M | 17.22%338.33M | 35.74%594.21M | 9.10%22.7M | 18.73%260.61M | 435.35%22.28M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 820.02M | 0 | 0 | 0 | -80.77%-4.65M | |||||
| Income from associates and other participating interests | -83.52%21.66M | 916.72%131.44M | 459.62%111.28M | 243.99%13.48M | -18.39%12.93M | 19.89M | ||||
| Special income (charges) | 33,712.71%11.23B | 49.71%-33.41M | -3,120.95%-19.68M | 20.04%-6.94M | 99.54%-185K | 61.21%-6.6M | -536.83%-66.42M | -8,628.57%-611K | 46.07%-8.68M | -40.11M |
| Less:Restructuring and mergern&acquisition | ---11.69B | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 466.10%189.11M | -49.71%33.41M | 3,120.95%19.68M | -20.04%6.94M | -99.54%185K | -61.21%6.6M | 536.83%66.42M | 8,628.57%611K | -46.07%8.68M | --40.11M |
| Less:Write off | --275.82M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 110.81%16.34M | -287.35%-151.18M | -375.49%-279.36M | 748.76%118.72M | 62.83%933K | 65.22%8.53M | -321.89%-39.03M | -360.43%-58.75M | 246.37%13.99M | -97.58%573K |
| Income before tax | 343.09%16.77B | -10.90%3.78B | -36.40%984.73M | -26.02%989.61M | 56.00%891.04M | 16.28%918.42M | 8.30%4.25B | 194.15%1.55B | 6.61%1.34B | -29.05%571.17M |
| Income tax | 98.72%1.99B | -6.54%1B | -40.25%264.31M | -19.45%305.25M | -17.80%165.72M | 445.48%266.37M | -8.00%1.07B | 206.53%442.33M | 18.20%378.94M | -31.51%201.6M |
| Net income | 431.06%14.78B | -12.38%2.78B | -34.86%720.42M | -28.61%684.37M | 96.26%725.32M | -12.00%652.05M | 15.19%3.18B | 189.48%1.11B | 2.63%958.69M | -27.64%369.57M |
| Net income continuous operations | 431.06%14.78B | -12.38%2.78B | -34.85%720.42M | -28.61%684.37M | 96.26%725.32M | -12.00%652.05M | 15.19%3.18B | 189.48%1.11B | 2.63%958.69M | -27.64%369.57M |
| Noncontrolling interests | -74.56M | 0 | ||||||||
| Net income attributable to the company | 433.74%14.85B | -12.38%2.78B | -34.86%720.42M | -28.61%684.37M | 96.26%725.32M | -12.00%652.05M | 15.19%3.18B | 189.48%1.11B | 2.63%958.69M | -27.64%369.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 433.74%14.85B | -12.38%2.78B | -34.86%720.42M | -28.61%684.37M | 96.26%725.32M | -12.00%652.05M | 15.19%3.18B | 189.48%1.11B | 2.63%958.69M | -27.64%369.57M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 437.00%372.25 | -13.57%69.32 | -36.07%17.85 | -29.92%16.98 | 93.78%18.08 | -12.34%16.41 | 15.16%80.2 | 189.33%27.92 | 2.63%24.23 | -27.67%9.33 |
| Diluted earnings per share | 437.00%372.25 | -13.57%69.32 | -36.03%17.85 | -29.98%16.9602 | 93.78%18.08 | -12.34%16.41 | 15.16%80.2 | 189.17%27.905 | 2.63%24.2221 | -27.67%9.33 |
| Dividend per share | 0.00%16 | 14.29%16 | 14.29%16 | 0 | 0 | 0 | 16.67%14 | 16.67%14 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |